Clinical Trial Detail

NCT ID NCT03597581
Title A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rgenix, Inc.

pancreatic adenocarcinoma

small intestine adenocarcinoma

colorectal adenocarcinoma

biliary tract cancer

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma



Fluorouracil + Irinotecan + Leucovorin + RGX202

Age Groups: adult senior

No variant requirements are available.